Latest News

Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering.

This year’s awardees are tackling some of the most urgent life science challenges with projects spanning novel therapeutics to AI-powered medical solutions.

Gut bacteria are increasingly implicated in non-gut-related autoimmune diseases. Yale researchers have begun to understand how they’re connected.

Metabolic liver diseases are on the rise in Connecticut. Yale faculty joined a new state working group to respond to the increase in the prevalence of these diseases. The working group recently issued recommendations to increase awareness and education and improve public health infrastructure.

And some may be under the impression that a glass of wine with dinner is actually healthy, Dr. Bubu Banini, assistant professor of medicine in digestive diseases at the Yale School of Medicine, tells TODAY.com.

Learn about the link between alcohol and cancer risk for women, including breast cancer & heart disease. Explore expert insights and prevention tips.

The Trust Your Gut continuing medical education (CME) series is returning for 2025 to provide physicians and advanced practice providers with world-class, evidence-based digestive disease education. Each webinar will be delivered by experts across the Yale School of Medicine.

From novel therapeutic treatments for obesity and endometriosis to a simulated psychedelic immersive experience to treat depression and a unisex non-hormonal contraceptive, the 2024 Yale Life Science PitchFest showcased Yale's most promising life science innovations from 34 Yale faculty-led teams.

Babesiosis, a tick-borne disease caused by Babesia parasites, is on the rise in the United States. The disease often presents with flu-like symptoms, but in some individuals, can progress to a more severe condition. Yet, despite the increasing significance of babesiosis in public health, there is limited understanding of the parasites’ biology, pathogenesis, and mechanism of virulence. Building on research initially reported in 2018 by a team of scientists led by Choukri Ben Mamoun, PhD, professor of medicine (infectious diseases), of microbial pathogenesis, and of pathology at Yale School of Medicine, the National Institutes of Health (NIH) awarded a $834,372 grant to further investigate Babesia biology and pathogenicity.